Regional hyperthermia (RHT) combined with gemcitabine (G) plus cisplatin (P) in patients (pts) with advanced pancreatic adenocarcinoma (APC)

被引：0
|
作者：
Tschoep, K. E. [1 ]
Milani, V. [1 ]
Lindner, L. H. [1 ]
Boeck, S. [1 ]
Berger, F. [2 ]
Dieterle, N. [1 ]
Abdel-Rahman, S. [1 ]
Salat, C. [3 ]
Issels, R. D. [1 ]
机构：
[1] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Klin Nukl Med, D-8000 Munich, Germany
[3] Hamatoonkol Schwerpunktpraxis & Tagesklin, Munich, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [41] Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma
    Ulrich-Pur, H
    Raderer, M
    Kornek, GV
    Schüll, B
    Schmid, K
    Haider, K
    Kwasny, W
    Depisch, D
    Schneeweiss, B
    Lang, F
    Scheithauer, W
    BRITISH JOURNAL OF CANCER, 2003, 88 (08) : 1180 - 1184
  • [42] TH-302+GEMCITABINE (G plus T) VS GEMCITABINE (G) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED PANCREATIC CANCER (PAC)
    Borad, M.
    Reddy, S.
    Bahary, N.
    Uronis, H.
    Sigal, D. S.
    Cohn, A. L.
    Schelman, W.
    Stephenson, J.
    Eng, C.
    Ryan, D. P.
    ANNALS OF ONCOLOGY, 2012, 23 : 224 - 224
  • [43] Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
    Liu, Xiaoyu
    Yang, Xuerong
    Zhou, Guofeng
    Chen, Yi
    Li, Changyu
    Wang, Xiaolin
    MEDICINE, 2016, 95 (11)
  • [44] A Phase II pilot trial of nivolumab (N) plus albumin bound paclitaxel (AP) plus paricalcitol (P) plus cisplatin (C) plus gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC)
    Borazanci, Erkut H.
    Jameson, Gayle
    Korn, Ronald Lee
    Caldwell, Lana
    Ansaldo, Karen
    Hendrickson, Kristin
    Marceau, Katie
    Gosselin, Kevin
    Von Hoff, Daniel D.
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Activity and tolerability of combination: capecitabine(c) plus gemcitabine(g) as first-line treatment in patients(pts) with locally advanced/metastatic pancreatic cancer
    Heras, P.
    Hatzopoulos, A.
    Karagianis, S.
    Mitsibounas, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 219 - 220
  • [46] Biweekly cisplatin (C) and gemcitabine (G) in patients (pts) with advanced biliary tract cancer (ABTC): A retrospective analysis.
    Ahn, Daniel H.
    Reardon, Josh
    Ahn, Chul
    Bupathi, Manojkumar
    Ciombor, Kristen Keon
    Wu, Christina Sing-Ying
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [47] Phase I study of trifluridine/tipiracil in combination with gemcitabine (gem) and nabpaclitaxel (nab-P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC).
    Turk, Anita Ahmed
    Helft, Paul R.
    Sehdev, Amikar
    Shahda, Safi
    Loehrer, Patrick J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 731 - 731
  • [48] A phase II pilot trial of nivolumab (N) plus albumin bound paclitaxel (AP) plus paricalcitol (P) plus cisplatin (C) plus gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC).
    Borazanci, Erkut
    Jameson, Gayle S.
    Sharma, Sunil
    Tsai, Frank
    Korn, Ronald L.
    Caldwell, Lana
    Ansaldo, Karen
    Ting, David T.
    Roe, Denise
    Bermudez, Anna
    Von Hoff, Daniel D.
    CANCER RESEARCH, 2021, 81 (22)
  • [49] A phase II pilot trial of nivolumab (N) plus albumin bound paclitaxel (AP) plus paricalcitol (P) plus cisplatin (C) plus gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC).
    Borazanci, Erkut Hasan
    Jameson, Gayle S.
    Borad, Mitesh J.
    Ramanathan, Ramesh K.
    Korn, Ronald Lee
    Caldwell, Lana
    Ansaldo, Karen
    Hendrickson, Kristin
    Marceau, Katie
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [50] A phase Ib/II pilot trial with nab-paclitaxel plus gemcitabine plus cisplatin in patients (pts) with stage IV pancreatic cancer.
    Jameson, Gayle S.
    Borazanci, Erkut Hasan
    Babiker, Hani M.
    Poplin, Elizabeth
    Niewiarowska, Anna A.
    Gordon, Michael S.
    Barrett, Michael T.
    Ansaldo, Karen
    Lebron, Leticia
    Stoll, Amy C.
    Rosenthal, Adam
    Shemanski, Lynn R.
    Korn, Ronald Lee
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345